首页>
外国专利>
USE OF CITRAL FOR TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS
USE OF CITRAL FOR TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS
展开▼
机译:使用西他乐治疗局灶性部分性肾小球硬化症
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a new use of citral for manufacturing a medicament for treating focal segmental glomerulosclerosis (FSGS). Particularly, the present invention discloses that citral is effective in alleviating symptoms of FSGS, including reducing glomerular epithelial hyperplasia lesions (EPHLs), peri-glomerular inflammation or glomerular hyalinosis or sclerosis, and also reducing proteinuria or hematuria or lowering serum urea nitrogen level or serum creatinine level in the subject.
展开▼